<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <title>Funding</title>
 <p>J.B. was supported by an MRC research training and support grant awarded to (Ref 1240480). A.R. is a Jenner Investigator and Oxford Martin Fellow. This work was supported by the UK Department of Health through Innovate UK “New vaccines for global epidemics: development and manufacture” grants No. 972214 and 971557 (A.RS.), and also funded from an ODA budget (Global Health (ODA), 16/107/05 (Design, development and GMP manufacture of a Zika vaccine). This research is funded by the Department of Health and Social Care using UK Aid funding and is managed by the NIHR. The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health and Social Care.</p>
</notes>
